+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

U.S. Patient Monitoring Market by Component: Opportunity Analysis and Industry Forecast, 2020-2027

  • ID: 5157205
  • Report
  • August 2020
  • Region: United States
  • 200 pages
  • Allied Analytics LLP
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now
The U.S. patient monitoring market was valued at $12,200.96 million in 2019, and is projected to reach $22,583.40 million by 2027, registering a CAGR of 5.21% from 2020 to 2027. Patient monitoring is the observation of a disease, condition or one or several medical parameters over time. Various types of patient monitoring systems is used to measure, record, distribute, and display combinations of biometric values such as heart rate, blood oxygen saturation levels (SPO2), blood pressure, and temperature. They is used to monitor patients regularly, which helps to avoid serious problems which helps to reduce number of emergency department visits and duration of hospitalization. Patient monitoring devices such as pulse oximeters, capnographs, and cardiac monitors are increasingly used in major hospitals, clinics, and various outpatient centers. These devices are commonly used during minor and major surgeries to monitor physiological signs of patients and intervene, if any complications occur. These devices can also help healthcare professionals to monitor vital signs of multiple patients at the same time. Some of these devices are also used to alert physicians, in case parameter levels are either above or below the limit set by physicians. Moreover, with the help of remote monitoring devices, physicians can remotely monitor physiological parameters such as blood glucose level, blood pressure, and heart rate; and accordingly provide appropriate treatment for patients.

Increase in geriatric population and rise in adoption of remote patient monitoring devices are one of the few factors that drive the growth of the market. In addition, rise in prevalence of chronic diseases such as COPD, diabetes, cancer, and atherosclerosis also contribute toward growth of the patient monitoring devices market. Moreover, collaborations between companies, hospitals, and academic institutions are expected to lead to launch of new products, which would help increase the market revenue and, therefore, boost the market growth. However, data privacy & security issues are likely to restrain growth of the market. Moreover, government regulations and reimbursement issues also hamper growth of the U.S patient monitoring system market. Conversely, an increase in adoption of AI and analytics is expected to create lucrative opportunities for the market during the forecast period. Further, growth in IoT healthcare applications is also projected to provide significant growth opportunities for the U.S. patient monitoring market.

Though most of the markets are dropping down, COVID-19 outbreak has positively affected various healthcare related markets, one of them being patient monitoring systems. As patient monitoring systems play a crucial role to combat pandemic and monitor patients, the patient monitoring market is witnessing a tremendous growth. Patient monitoring systems including cardiac monitors, respiratory devices, and temperature monitoring devices are facing huge demand, owing to their immense use in patient treatment along with IoT technology. In addition, IoT, specifically when combined with other transformative technologies such as Cloud and Artificial intelligence (AI), lead to a wide range of applications in patient monitoring, which have been beneficial during the crisis.

The U.S. patient monitoring system market is segmented into component which is further sub-segmented into devices, services, and connectivity type. By device, the market is further categorized into hemodynamic monitoring devices, neuromonitoring devices, cardiac monitoring devices, fetal & neonatal monitoring devices, respiratory monitoring devices, multiparameter monitoring devices, weight monitoring devices, temperature monitoring devices, and urine output monitoring devices. The service type segment is further divided into consulting, system integration & deployment, and support & maintenance. The connectivity technology type segment is further categorized into cellular IoT- 3G, cellular IoT- 4G, LoRa, Wi-Fi, SIGFOX, wireline, wireless personal area network (WPAN), and others.

The report provides extensive competitive analysis and profiles of key market players such as Abbott Laboratories, Biotronik SE & CO. KG, Boston Scientific Corporation, Medtronic, Inc., F. Hoffmann-La Roche Ltd., GE Healthcare Ltd, Masimo Corporation, Nihon Kohden Corporation, OSI Systems, Inc. (Spacelabs Healthcare), and Koninklijke Philips N.V.

Key Benefits for Stakeholders
  • This report provides a detailed quantitative analysis of the current U.S. patient monitoring system market trends and future estimations from 2020 to 2027, which assists in identifying the prevailing market opportunities.
  • An in-depth analysis of country is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate country specific plans.
  • A comprehensive analysis of the factors that drive and restrain the growth of the U.S. patient monitoring system market is provided.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.
Key Market Segments

By Component
  • Devices
  • Hemodynamic Monitoring Devices
  • Neuromonitoring Devices
  • Cardiac Monitoring Devices
  • Fetal and Neonatal Monitoring Devices
  • Respiratory Monitoring Devices
  • Multiparameter Monitoring Devices
  • Remote Patient Monitoring Devices
  • Weight Monitoring Devices
  • Temperature Monitoring Devices
  • Urine Output Monitoring Devices
  • Service
  • Consulting
  • System Integration and Deployment
  • Support and Maintenance
  • Connectivity Technology
  • Cellular IoT- 3G
  • Cellular IoT- 4G
  • Wi-Fi
  • SIGFOX
  • Wireline
  • Wireless Personal Area Network (WPAN)
  • Others
List of key players profiled in the report
  • Abbott Laboratories
  • Biotronik
  • Boston Scientific Corporation
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare Ltd
  • Koninklijke Philips N.V.
  • Masimo Corporation
  • Medtronic, Inc.
  • Nihon KohdenCorporation
  • OSI Systems, Inc. (Spacelabs Healthcare)
LIST OF OTHER PLAYERS IN THE VALUE CHAIN(These players are not profiled in the report. The same will be included on request.)
  • Cisco Systems Inc.
  • Schiller AG
  • Omron Healthcare Co. Ltd.
Note: Product cover images may vary from those shown
2 of 3
Chapter 1: Introduction
1.1. Report Description
1.2. Key Benefits
1.3. Key Market Segments
1.4. Research Methodology
1.4.1. Secondary Research
1.4.2. Primary Research
1.4.3. Analyst Tools and Models

Chapter 2: Executive Summary
2.1. Cxo Perspective

Chapter 3: Market Overview
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Top Player Positioning
3.4. Porter’S Five Forces Analysis
3.5. Covid-19 Impact on the Market
3.6. Government Regulations
3.6.1. U.S. Fda
3.7. Reimbursement Scenarios
3.8. Clinical Trials
3.9. Patent Analysis
3.9.1. Patents Registered/Approved, 2011–2020
3.9.2. Patents Registered/Approved, by Applicants, 2011–2020
3.9.3. U.S. Patent Analysis, by Market Applicants
3.10. Market Dynamics
3.10.1. Drivers
3.10.1.1. Rise in Prevalence of Lifestyle Diseases
3.10.1.2. Increase in Geriatric Population
3.10.1.3. Rise in the Adoption of Remote Patient Monitoring Devices
3.10.2. Restraints
3.10.2.1. Government Regulations and Reimbursement Issues
3.10.2.2. Limited Awareness and High Costs
3.10.3. Opportunities
3.10.3.1. Technological Advancements

Chapter 4: Patient Monitoring Systems Market, by Component
4.1. Overview
4.1.1. Market Size and Forecast
4.2. Device
4.2.1. Market Size and Forecast
4.2.2. Hemodynamic Monitoring Devices
4.2.2.1. Key Market Trends and Opportunity
4.2.2.2. Market Size and Forecast
4.2.3. Neuromonitoring Devices
4.2.3.1. Key Market Trends and Opportunities
4.2.3.2. Market Size and Forecast
4.2.4. Cardiac Monitoring Devices
4.2.4.1. Key Market Trends and Opportunities
4.2.4.2. Market Size and Forecast
4.2.5. Fetal Neonatal Monitoring Devices
4.2.5.1. Key Market Trends and Opportunities
4.2.5.2. Market Size and Forecast
4.2.6. Respiratory Monitors
4.2.6.1. Key Market Trends and Opportunities
4.2.6.2. Market Size and Forecast
4.2.7. Multiparameter Monitoring Devices
4.2.7.1. Key Market Trends and Opportunities
4.2.7.2. Market Size and Forecast
4.2.8. Remote Patient Monitoring Devices
4.2.8.1. Key Market Trends and Opportunities
4.2.8.2. Market Size and Forecast
4.2.9. Weight Monitoring Devices
4.2.9.1. Key Market Trends and Opportunities
4.2.9.2. Market Size and Forecast
4.2.10. Temperature Monitoring Devices
4.2.10.1. Key Market Trends and Opportunities
4.2.10.2. Market Size and Forecast
4.2.11. Urine Output Monitoring
4.2.11.1. Key Market Trends and Opportunities
4.2.11.2. Market Size and Forecast
4.3. Service
4.3.1. Market Size and Forecast
4.3.2. Consulting
4.3.2.1. Market Size and Forecast
4.3.3. System Integration and Deployment
4.3.3.1. Market Size and Forecast
4.3.4. Support and Maintenance
4.3.4.1. Market Size and Forecast
4.4. Connectivity Technology
4.4.1. Cellular IoT - 3G
4.4.1.1. Market Size and Forecast
4.4.2. Cellular IoT - 4G
4.4.2.1. Market Size and Forecast
4.4.3. Wi-Fi
4.4.3.1. Market Size and Forecast
4.4.4. Sigfox
4.4.4.1. Market Size and Forecast
4.4.5. Wireline
4.4.5.1. Market Size and Forecast
4.4.6. Wireless Personal Area Network (Wpan)
4.4.6.1. Market Size and Forecast
4.4.7. Others
4.4.7.1. Market Size and Forecast

Chapter 5: Company Profiles
5.1. Abbott Laboratories
5.1.1. Company Overview
5.1.2. Company Snapshot
5.1.3. Operating Business Segments
5.1.4. Product Portfolio
5.1.5. Business Performance
5.1.6. Key Strategic Moves and Developments
5.2. Biotronik Se & Co. Kg
5.2.1. Company Overview
5.2.2. Company Snapshot
5.2.3. Operating Business Segments
5.2.4. Product Portfolio
5.2.5. Key Strategic Moves and Developments
5.3. Boston Scientific Corporation
5.3.1. Company Overview
5.3.2. Company Snapshot
5.3.3. Operating Business Segments
5.3.4. Product Portfolio
5.3.5. Business Performance
5.3.6. Key Strategic Moves and Developments
5.4. General Electric Company (Ge Healthcare)
5.4.1. Company Overview
5.4.2. Company Snapshot
5.4.3. Operating Business Segments
5.4.4. Product Portfolio
5.4.5. Business Performance
5.4.6. Key Strategic Moves and Developments
5.5. F. Hoffmann-La Roche Ltd.
5.5.1. Company Overview
5.5.2. Company Snapshot
5.5.3. Operating Business Segments
5.5.4. Product Portfolio
5.5.5. Business Performance
5.5.6. Key Strategic Moves and Developments
5.6. Koninklijke Philips N. V. (Philips Healthcare)
5.6.1. Company Overview
5.6.2. Company Snapshot
5.6.3. Operating Business Segments
5.6.4. Product Portfolio
5.6.5. Business Performance
5.6.6. Key Strategic Moves and Developments
5.7. Masimo Corporation
5.7.1. Company Overview
5.7.2. Company Snapshot
5.7.3. Product Portfolio
5.7.4. Business Performance
5.7.5. Key Strategic Moves and Developments
5.8. Medtronic plc.
5.8.1. Company Overview
5.8.2. Company Snapshot
5.8.3. Operating Business Segments
5.8.4. Medtronic Offers Following Patient Monitoring Devices
5.8.5. Business Performance
5.8.6. Key Strategic Moves and Developments
5.9. Nihon Kohden Corporation
5.9.1. Company Overview
5.9.2. Company Snapshot
5.9.3. Operating Business Segments
5.9.4. Product Portfolio
5.9.5. Business Performance
5.9.6. Key Strategic Moves and Developments
5.10. Osi Systems, Inc. (Spacelabs Healthcare)
5.10.1. Company Overview
5.10.2. Company Snapshot
5.10.3. Operating Business Segments
5.10.4. Product Portfolio
5.10.5. Business Performance
5.10.6. Key Strategic Moves and Development
Note: Product cover images may vary from those shown
3 of 3

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll